Tag: Resolute Onyx

Resolute Onyx™ DES Meets Primary Endpoint in First-Ever Clinical Study Comparing Drug-Eluting Stents in High-Bleeding Risk (HBR) Patients with One-Month DAPT

Coronary/Structural Heart by 0 comments

DUBLIN and SAN FRANCISCO, Sept. 26, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) announced today late-breaking clinical data from the Onyx ONE Global Study, representing the first prospective, multi-center, randomized study evaluating clinical outcomes between two drug-eluting stents (DES) in nearly 2,000 high-bleeding […]

Continue Reading →

Medtronic Launches Resolute Onyx (TM) Drug-Eluting Stent in US Following FDA Approval Becoming First DES Available in 4.5mm and 5mm Sizes

Coronary/Structural Heart by 0 comments

By GlobeNewswire Engineered for Exceptional Deliverability, Advanced DES Technology Features Thinner Struts, Enhanced Visibility and the Broadest Size Matrix in the U.S. DUBLIN – May 1, 2017 -Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval […]

Continue Reading →